- $315.99m
- $1.24bn
- $0.89m
Palihapitiya-backed SPAC tumbles ahead of ProKidney deal vote
Brief: ProKidney Announces Manufacturing Efficiency Initiatives And Supply Chain Streamlining
Brief: Prokidney - Announced An Update On Its Regen-007 Phase 2 Clinical Study Of React
Brief: ProKidney confirms Phase 3 program for autologous kidney cell therapy REACT
Brief: Revolutionary Chronic Kidney Disease Therapeutics Company Prokidney To Publicly Traded Via Business Combination With Social Capital Suvretta Holdings
Palihapitiya-backed SPAC to take ProKidney public in $2.64 bln deal
NASDAQ RESUMED AT 07:30 AM
Palihapitiya-backed SPAC to take ProKidney public in over $2 bln deal (updated)
Palihapitiya-backed SPAC to take ProKidney public in over $2 bln deal
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
Blank-check firm Social Capital edges up on $1 bln merger talks with ProKidney
Media: Palihapitiya SPAC is said to be in merger talks with ProKidney - Bloomberg News
NASDAQ RESUMED AT 11:50 AM
Four Palihapitiya-backed SPACs raise $880 mln in upsized public offerings
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:02 AM